- Home
- SLDB vs KNOP Comparison
SLDB vs KNOP Comparison
Compare SLDB & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- KNOP
- Stock Information
- Founded
- SLDB 2013
- KNOP 2013
- Country
- SLDB United States
- KNOP United Kingdom
- Employees
- SLDB N/A
- KNOP N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- KNOP Marine Transportation
- Sector
- SLDB Health Care
- KNOP Consumer Discretionary
- Exchange
- SLDB Nasdaq
- KNOP Nasdaq
- Market Cap
- SLDB 227.3M
- KNOP 213.1M
- IPO Year
- SLDB 2018
- KNOP 2013
- Fundamental
- Price
- SLDB $4.03
- KNOP $5.51
- Analyst Decision
- SLDB Strong Buy
- KNOP
- Analyst Count
- SLDB 11
- KNOP 0
- Target Price
- SLDB $17.91
- KNOP N/A
- AVG Volume (30 Days)
- SLDB 279.8K
- KNOP 101.5K
- Earning Date
- SLDB 11-06-2024
- KNOP 12-04-2024
- Dividend Yield
- SLDB N/A
- KNOP 1.89%
- EPS Growth
- SLDB N/A
- KNOP N/A
- EPS
- SLDB N/A
- KNOP N/A
- Revenue
- SLDB N/A
- KNOP $299,790,000.00
- Revenue This Year
- SLDB N/A
- KNOP $7.66
- Revenue Next Year
- SLDB N/A
- KNOP $1.75
- P/E Ratio
- SLDB N/A
- KNOP N/A
- Revenue Growth
- SLDB N/A
- KNOP 4.75
- 52 Week Low
- SLDB $4.00
- KNOP $4.94
- 52 Week High
- SLDB $15.05
- KNOP $9.11
- Technical
- Relative Strength Index (RSI)
- SLDB 29.01
- KNOP 32.07
- Support Level
- SLDB $4.82
- KNOP $5.36
- Resistance Level
- SLDB $5.40
- KNOP $5.98
- Average True Range (ATR)
- SLDB 0.34
- KNOP 0.23
- MACD
- SLDB -0.08
- KNOP -0.02
- Stochastic Oscillator
- SLDB 1.63
- KNOP 17.50
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.